The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.
Paris, France, October 22, 2019
The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.
Certified Genopole, PhinC Development, the expert partner in early development of drug candidates and in pharmacokinetic modeling and pharmacometry, today announces the launch of a new subsidiary in Montreal, Canada.
PhInc. Modeling strengthens PhinC’s presence in North America, which already opened its first offices in Montreal. Indeed, the North American market is an important focus for companies, such as PhinC, that offers a strategy of modeling and simulation to accelerate drug development: the USA and Canada represent over 40% of the CRO (Contract Research Organization) market size, based on the number of trials being conducted in each country/region.
“We believe that our new subsidiary in Montreal will reinforce our relationship with our North American Clients and Partners by getting closer to them. It will allow us to offer better adapted services and improved response time to their needs” said Bernard Orlandini, Managing director of PhinC Development. Virginie Gualano, President of PhInc. Modeling, continues “Our new location will also enable us to closely observe technology improvements, forge new partnerships and provide more opportunities to attend key industry events.”
The team also aim to attend several conferences in North America starting from this year. Setting up partnerships with local specialized companies also figures among the priorities of PhinC Development.
Jean-Marc Grognet, General Director of Genopole: “The success of PhinC Development, a company born in Genopole, is our pride! We carry a strong ambition of international outreach and for that we engage a very voluntaristic policy of partnership with foreign bioclusters, in particular on the other side of the Atlantic. The contacts we made last year in Quebec, with Marianne Duranton, Vice-president of Genopole and Denis Gauvreau, International Director of Genopole, have paid off, and we are delighted. This is our goal: to contribute to the international deployment of the genopolitan companies and thus accelerate their growth”.
About PhinC Development
PhinC Development is the expert partner for small to medium size pharmaceutical or biotech companies, who need to move forward in early drug research. Thanks to a multidisciplinary team with thorough field experience, PhinC helps to take the best decisions concerning drug development using all existing pharmacology and pharmacometrics Modeling & Simulation (M&S) tools. From drug candidate optimization to Patient Proof of Concept (PoC), PhinC helps small and big pharma to design their development and supervise its good execution. The Model-Informed Drug Development used by the company increases confidence in decision making and reduces cycle time of the development of its clients.
https://www.phinc-development.
About the GENOPOLE
Genopole, France’s leading biocluster for biotechnologies and research in genomics and genetics, unites innovative high-tech life science companies, public and private research and higher education facilities at a single site in Evry/Corbeil-Essonnes, just south of Paris. Genopole is a pioneer in France and brings together 96 biotech companies, 16 research laboratories, 29 technological platforms, as well as university (University of Evry, Paris Saclay). Its goal: to create and support biotechnology companies and the transfer of technology to the industrial sector, fostering the development of research in life sciences, develop high-level teaching in these areas. Directed by Jean-Marc Grognet, Genopole is mainly supported by the State, Ile-de-France Region, the Department of Essonne, Grand Paris Sud, Evry-Courcouronnes and AFM-Téléthon.
https://www.genopole.fr/ contact: anne.rohou@genopole.fr Tel : 01 60 87 83 10
